Biotech/Biopharma Analyst Chen, along with Global Therapeutic Area Head-Oncology, Peter Lebowitz, VP-Oncology Medical Affairs Wildgust, and Oncology VP Naumovic discuss the recently-held ESMO Event on an Analyst/Industry conference call to be held on October 26 at 11 am. Webcast Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ:
- Janssen says Rybrevant combination study showed 30% risk reduction
- New Dengue Pill from Johnson & Johnson (NYSE:JNJ) Gives Shares a Boost
- Janssen announces Phase 3b Week 16 results from Cohort A of VISIBLE trial
- CVS removing certain cold medicines containing phenylephrine, CNBC reports
- Johnson & Johnson price target raised to $165 from $162 at Barclays